Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Plus Therapeutics (PSTV) Change in Intangibles (2022)

Plus Therapeutics (PSTV) has disclosed Change in Intangibles for 3 consecutive years, with $117000.0 as the latest value for Q1 2022.

  • On a quarterly basis, Change in Intangibles changed N/A to $117000.0 in Q1 2022 year-over-year; TTM through Mar 2023 was $117000.0, a 0.0% change, with the full-year FY2024 number at $545000.0, changed N/A from a year prior.
  • Change in Intangibles was $117000.0 for Q1 2022 at Plus Therapeutics, up from $13000.0 in the prior quarter.
  • In the past five years, Change in Intangibles ranged from a high of $117000.0 in Q1 2022 to a low of $117000.0 in Q1 2022.